Found vs Mochi Health (2026): prices, structure, verdict

On tirzepatide, Mochi Health↗ is cheaper: $278 versus $289 a month all-in — a $11 monthly gap, $132 across a year of maintenance dosing.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, Mochi Health is cheaper: $178 versus $289 a month all-in — a $111 monthly gap, $1,332 across a year of maintenance dosing.

§ Side by side

§ Each record, read aloud

The two records, condensed

Found: the record, condensed

Found’s tirzepatide program bills $289 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Found is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

There is no membership line. $289 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #6 of 17 in the verified tirzepatide index — $74/month above the floor (NexLife↗, $215) — and sits $160 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $3,468.

Start with the load-bearing figure: $289 a month, all-in, is what Found charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #15 of 20 verified programs, with the floor $156/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare↗)) sits at $349, so the compounded case here is worth $60 a month. A year at this figure: $3,468 monthly-billed.

Operationally at Found: shipping included; commitment none month-to-month; prepaid terms for lowest rate; cancellation membership recurs; prepaid terms are paid up front; pharmacy not publicly named — ask in writing before paying; states: most states; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Found page · visit Found ↗

Mochi Health: the record, condensed

On tirzepatide, the number that matters at Mochi Health is $278 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Mochi Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

The all-in figure already contains a compulsory $79 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $199 would be exactly that kind of mirage.

Context for that figure: it ranks #4 of 17 in the verified tirzepatide index — $63/month above the floor (NexLife, $215) — and sits $171 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $3,336.

On semaglutide, the number that matters at Mochi Health is $178 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

The all-in figure already contains a compulsory $79 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $99 would be exactly that kind of mirage.

To place the number: #8 of 20 verified programs, with the floor $45/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $171 a month. A year at this figure: $2,136 monthly-billed.

Operationally at Mochi Health: shipping included; commitment membership recurs monthly; cancellation cancel membership any time; recurs until cancelled; pharmacy named (company-owned compounding facility); states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Mochi Health page · visit Mochi Health ↗

Tirzepatide: the duel in full

The tirzepatide arithmetic between these two is short: $278 (Mochi Health) against $289 (Found). $11 a month sounds survivable; $132 a year is a decision.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $11 gap is exactly what it appears to be.

Mochi Health’s total includes a mandatory $79/month membership; Found has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

Semaglutide: the duel in full

Put the two semaglutide figures side by side and hold them there: Mochi Health at $178, Found at $289 — a $111 monthly spread that compounds to $1,332 over a maintenance year and $2,664 over two.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $111 gap is exactly what it appears to be.

Mochi Health’s total includes a mandatory $79/month membership; Found has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

Translate the $11/month spread into medication: $132 a year equals roughly 0.5 months of therapy at the cheaper program’s rate. That is the honest unit for gaps in this market — months of treatment, not abstract dollars — and it is why small-looking monthly differences decide long courses.

On best published rate — the lower of each program’s month-to-month price and its labeled 12-month-plan rate, which is the sort most price roundups quietly run — the duel reads: Found $289/mo month-to-month versus Mochi Health $278/mo month-to-month. Same winner on both bases — Mochi Health leads whether you compare month-to-month prices or committed-plan rates, which makes this one of the cleaner verdicts in the index. Prepaid rates are upfront commitments with refund terms to verify before they count.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: Found $867 monthly; Mochi Health $834 monthly — best path favors Mochi Health by $33. 6 months: Found $1,734 monthly; Mochi Health $1,668 monthly — best path favors Mochi Health by $66. 12 months: Found $3,468 monthly; Mochi Health $3,336 monthly — best path favors Mochi Health by $132. 24 months: Found $6,936 monthly; Mochi Health $6,672 monthly — best path favors Mochi Health by $264.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

The same clock, on semaglutide

3 mo: Found $867 vs Mochi Health $534 — $333 to Mochi Health. 6 mo: Found $1,734 vs Mochi Health $1,068 — $666 to Mochi Health. 12 mo: Found $3,468 vs Mochi Health $2,136 — $1,332 to Mochi Health. 24 mo: Found $6,936 vs Mochi Health $4,272 — $2,664 to Mochi Health.

Same rules as above: prepaid figures are upfront commitments, and the 24-month lines extend the 12-month rate as a stated assumption. Where the two molecules crown different winners between these two programs, that split is itself the finding — molecule choice and provider choice are separate decisions.

§ Structure vs structure

Everything besides the price

Coverage: Found publishes “most states”; Mochi Health publishes “most states” — for anything short of an explicit 50-state claim, intake is the final word.

Pharmacy transparency splits them: Mochi Health names its network (company-owned compounding facility); Found does not, which shifts the burden of verification onto your intake questions.

Exit terms: Found — none month-to-month; prepaid terms for lowest rate; membership recurs; prepaid terms are paid up front. Mochi Health — membership recurs monthly; cancel membership any time; recurs until cancelled.

Insurance: only Found does coverage work — decisive if there is any chance your plan covers a brand GLP-1, because a covered prescription beats both cash paths on this page.

Evidence: Found third-party reported (captured 2026-08-05); Mochi Health source-verified (2026-08-05).

A rule that has held across this index: disclosure predicts disclosure. Whichever of these two publishes more — pharmacies, states, exit terms — is usually the one whose invoice matches its ad.

In the full tirzepatide index these two sit at #6 and #4 of 17: between them lie 1 other program, and the whole ladder is at cheapest tirzepatide providers. In the full semaglutide index these two sit at #15 and #8 of 20: between them lie 6 other programs, and the whole ladder is at cheapest semaglutide providers.

§ If you move

Switching between Found and Mochi Health

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Found: membership recurs; prepaid terms are paid up front; Mochi Health: cancel membership any time; recurs until cancelled) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings